| Basic and Diluted Net Loss Per Share |
NOTE 16 – BASIC AND DILUTED NET LOSS PER SHARE
The following table sets forth the computation
of the Company’s basic and diluted net loss per share for:
| |
|
Three-months ended March 31, 2021 (Unaudited) |
|
| |
|
Net Loss (Numerator) |
|
|
Shares (Denominator) |
|
|
Per share
amount |
|
| Basic loss per share |
|
$ |
(1,382,118 |
) |
|
|
794,183 |
|
|
$ |
(1.74 |
) |
| Effect of dilutive securities—Common stock options, warrants, convertible notes, and preferred stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(1,382,118 |
) |
|
|
794,183 |
|
|
$ |
(1.74 |
) |
| |
|
Three-months ended March 31, 2020 (Unaudited) |
|
| |
|
Net Loss (Numerator) |
|
|
Shares (Denominator) |
|
|
Per share
amount |
|
| Basic loss per share |
|
$ |
(1,002,868 |
) |
|
|
700,879 |
|
|
$ |
(1.43 |
) |
| Effect of dilutive securities—Common stock options, warrants, and convertible notes |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(1,002,868 |
) |
|
|
700,879 |
|
|
$ |
(1.43 |
) |
The following outstanding shares of common
stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would
have been antidilutive for the periods ended:
| |
|
March 31, 2021 |
|
|
March 31, 2020 |
|
| |
|
(Unaudited) |
|
|
(Unaudited) |
|
| Common stock underlying convertible notes |
|
|
688,147 |
|
|
|
443,410 |
|
| Common stock underlying options |
|
|
141,122 |
|
|
|
202,246 |
|
| Common stock underlying warrants |
|
|
901,199 |
|
|
|
447,036 |
|
| Common stock underlying preferred stock |
|
|
10,172 |
|
|
|
- |
|
| Total common stock equivalents |
|
|
1,740,640 |
|
|
|
1,092,692 |
|
|